FELBATOL- felbamate tablet
FELBATOL- felbamate suspension Stati Uniti - Ingliż - NLM (National Library of Medicine)

felbatol- felbamate tablet felbatol- felbamate suspension

meda pharmaceuticals inc. - felbamate (unii: x72rbb02n8) (felbamate - unii:x72rbb02n8) - felbamate 400 mg - felbatol® is not indicated as a first line antiepileptic treatment (see warnings ). felbatol® is recommended for use only in those patients who respond inadequately to alternative treatments and whose epilepsy is so severe that a substantial risk of aplastic anemia and/or liver failure is deemed acceptable in light of the benefits conferred by its use. if these criteria are met and the patient has been fully advised of the risk, and has provided written acknowledgement, felbatol® can be considered for either monotherapy or adjunctive therapy in the treatment of partial seizures, with and without generalization, in adults with epilepsy and as adjunctive therapy in the treatment of partial and generalized seizures associated with lennox-gastaut syndrome in children. felbatol® is contraindicated in patients with known hypersensitivity to felbatol®, its ingredients, or known sensitivity to other carbamates. it should not be used in patients with a history of any blood dyscrasia or hepatic dysfunctio

Tegretol 100mg/5ml liquid Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

tegretol 100mg/5ml liquid

novartis pharmaceuticals uk ltd - carbamazepine - oral suspension - 20mg/1ml